DePuy hip recall: Senate to probe safety of medical devices

April 12, 2011 by MassDevice staff

The U.S. Senate's Special Committee on Aging will hear testimony on Johnson & Johnson subsidiary DePuy's hip recall as it focuses on patient safety in the approval process for medical devices.

capitol_100.jpg

This week isn't going to get any better for DePuy Inc., as the Johnson & Johnson (NYSE:JNJ) subsidiary is set to have its dirty laundry aired in front of a Senate panel tomorrow.

The U.S. Senate's Special Committee on Aging announced that the Warsaw, Ind.-based company's massive hip replacement system recall will be front and center during its examination of the FDA and its role in "protecting patient safety as part of the medical device approval process," according to a prepared release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp